2nd Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$2,520,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

16 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Agricultural Education Policy Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act EPA Regulations on Biotechnology ---H.R. 1029 Pesticide Registration Act ---Efficient Science-Based Reviews of Biotech Products Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for the USDA ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---Foreign Agriculture Service Funding and Authority ------H.R. 5379: Growing American Food Exports Act Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 ------Amendment on GE Salmon Labeling One Health ---S. 2615: Advancing Emergency Preparedness Through One Health Act Potential Regulation of New Genetic Modification Technologies Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---Potential Revisions to Part 340 Regulations ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Review of the Coordinated Framework for Biotechnology Products

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
JEANNE HAGGERTY —
DAN JENKINS —
KYLE KUNKLER —
SARAH KYLE —
JORDAN LAYSON —
ERICK LUTT —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —
RINA SINGH —

Contacted: Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Natl Security Council (NSC); Council of Economic Advisers (CEA); Natl Institutes of Health (NIH); SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); White House Office; Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Natl Economic Council (NEC); State, Dept of (DOS)

Bills named: S. 2476 (115th), H.R. 5379 (115th), S. 3042 (115th), H.R. 2 (115th), S. 2615 (115th), H.R. 5961 (115th), H.R. 1029 (115th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Biorefineries (non-funding) ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Energy Basic Research Funding ---DOE Office of Science ---Advanced Research Projects Agency-Energy ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act Review of the Federal Coordinated Framework for Biotechnology Products

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
CHARLES H FRITTS —
JEANNE HAGGERTY —
KYLE KUNKLER —
ERICK LUTT —
RINA SINGH —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Natl Security Council (NSC); Council of Economic Advisers (CEA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); SENATE; White House Office; Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA)

Bills named: S. 2005 (115th), S. 517 (115th), H.R. 4118 (115th), H.R. 2 (115th), S. 3042 (115th), H.R. 5961 (115th), H.R. 5895 (115th), S. 2976 (115th), H.R. 1311 (115th), S. 2975 (115th)

Health Issues HCR

340B Drug Discount Program ---Program Implementation & Oversight ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 4710: 340B Pause Act ---H.R. 5598: 340B Optimization Act ---S. 2453: Ensuring the Value of the 340B Program Act Access to Medicines/World Health Organization Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) ---S.2852: Pandemic and All-Hazards Preparedness and Innovation Act (PAHPAIA) Biosimilars ---Access to Samples for Testing ---Interchangeability and Pharmacy Substitution ---S. 974/H.R. 2212: CREATES Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Innovation Incentives ---Patient-Focused Drug Development ---S.204 / H.R. 878: Right to Try Act of 2017 ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---FDA Management & Financial Accountability ---FDA Hiring Flexibility ---Priority Review Voucher Program ---Regulatory Reform & Modernization ---Use of Real World Evidence Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight ---Drug Shortages ---Supply Chain Integrity and Traceability ---Counterfeiting Drug Pricing ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs Drug Product Communications Foreign Drug Data Protection Laws Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for FDA ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---Incentives for Generic Entry ---S. 974/H.R. 2212: CREATES Act of 2017 Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculations North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---IP Provisions Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Orphan Drug Issues ---Tax Credit Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6142/S. 2042: Reducing Drug Waste Act Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education ---H.R. 4993: Vaccine Access Improvement Act

Contacted: SENATE; Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Council of Economic Advisers (CEA); State, Dept of (DOS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); White House Office; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Agriculture, Dept of (USDA); Natl Economic Council (NEC)

Bills named: H.R. 3219 (115th), H.R. 2974 (115th), H.R. 6142 (115th), H.R. 878 (115th), S. 469 (115th), S. 1348 (115th), S. 2453 (115th), S. 2769 (115th), H.R. 6 (115th), S. 1369 (115th), S. 3158 (115th), S. 2665 (115th), S. 771 (115th), S. 974 (115th), S. 2976 (115th), H.R. 5961 (115th), H.R. 4993 (115th), S. 2852 (115th), H.R. 4710 (115th), S. 637 (115th), H.R. 5598 (115th), S. 1688 (115th), H.R. 1840 (115th), H.R. 2212 (115th), H.R. 5002 (115th), H.R. 5590 (115th), S. 2042 (115th), S. 2669 (115th), H.R. 5473 (115th), H.R. 5806 (115th), S. 204 (115th), S. 2680 (115th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Biorefineries (non-funding) ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Energy Basic Research Funding ---DOE Office of Science ---Advanced Research Projects Agency-Energy ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act Review of the Federal Coordinated Framework for Biotechnology Products

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
CHARLES H FRITTS —
JEANNE HAGGERTY —
KYLE KUNKLER —
ERICK LUTT —
RINA SINGH —

Contacted: Natl Economic Council (NEC); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Council of Economic Advisers (CEA); State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); White House Office; Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 2975 (115th), H.R. 5895 (115th), H.R. 4118 (115th), S. 2005 (115th), S. 517 (115th), H.R. 5961 (115th), S. 3042 (115th), H.R. 2 (115th), S. 2976 (115th), H.R. 1311 (115th)

Budget/Appropriations BUD

Energy Basic Research Funding ---Advanced Research Projects Agency-Energy ---DOE Office of Science ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for FDA ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Renewable Chemicals/Bio-based Products ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---EPA Safer Choice Program Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the USDA ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---Foreign Agriculture Service Funding and Authority ------H.R. 5379: Growing American Food Exports Act

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
PHYLLIS ARTHUR —
JEANNE HAGGERTY —
KYLE KUNKLER —
SARAH KYLE —
JORDAN LAYSON —
ERICK LUTT —
RINA SINGH —

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Natl Economic Council (NEC); Council of Economic Advisers (CEA); SENATE; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); White House Office; Agriculture, Dept of (USDA); State, Dept of (DOS)

Bills named: S. 3042 (115th), H.R. 5379 (115th), S. 3158 (115th), H.R. 5895 (115th), S. 2976 (115th), S. 2975 (115th), H.R. 2 (115th), H.R. 5961 (115th)

Small Business SMB

Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---Accelerated Filer Definition Short Selling Transparency XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act

LobbyistCovered position, as disclosed
CAMERON ARTERTON —
ELIZABETH CARTIER ESHAM —
JEANNE HAGGERTY —
DAVID LACHMANN —

Contacted: Patent & Trademark Office (PTO); Council of Economic Advisers (CEA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Security Council (NSC); State, Dept of (DOS); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); White House Office; Natl Economic Council (NEC); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Bills named: H.R. 10 (115th), H.R. 4015 (115th), S. 2126 (115th), H.R. 1645 (115th), H.R. 5054 (115th)

Trade (domestic/foreign) TRD

Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Foreign Drug Data Protection Laws Funding for the USDA ---Foreign Agriculture Service Funding and Authority ------H.R. 5379: Growing American Food Exports Act Intellectual Property International Enforcement ---Compulsory Licensing ---India ---Malaysia North American Free Trade Agreement (NAFTA) Renegotiation ---IP Provisions ---Pricing and Reimbursement Provisions Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
CHARLES H FRITTS —
JAMIE GREGORIAN —
JEANNE HAGGERTY —
KYLE KUNKLER —
DAVID LACHMANN —
JORDAN LAYSON —
MATTHEW O'MARA —
HANSJORG SAUER —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC); SENATE; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Natl Security Council (NSC); Food & Drug Administration (FDA); Council of Economic Advisers (CEA); U.S. Trade Representative (USTR); White House Office

Bills named: S. 469 (115th), H.R. 5379 (115th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Capital Formation Investment Incentives ---Reform of Net Operating Loss Rules Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---HR 3149/S. 1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Qualified Small Business Stock (QSBS) Research & Development Tax Credit Reforms ---Refundable R&D Credit Vaccines and Infectious Diseases ---Vaccine Injury Compensation Program ---H.R. 4993: Vaccine Access Improvement Act

LobbyistCovered position, as disclosed
CAMERON ARTERTON —
TAYLOR BOOTH —
ELIZABETH CARTIER ESHAM —
CHARLES H FRITTS —
JAMIE GREGORIAN —
JEANNE HAGGERTY —
ERICK LUTT —
RINA SINGH —

Contacted: Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Natl Security Council (NSC); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); White House Office; Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); Council of Economic Advisers (CEA); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Office of Management & Budget (OMB)

Bills named: H.R. 4993 (115th), S. 1980 (115th), H.R. 3149 (115th), S. 2005 (115th), H.R. 4118 (115th)

Copyright/Patent/Trademark CPT

Bayh-Dole Act/Tech Transfer ---March-In Rights Foreign Drug Data Protection Laws Intellectual Property International Enforcement ---Compulsory Licensing ---India ---Malaysia Inter Partes Review ---Implementation of the America Invents Act of 2011 ---H.R. 5340/S. 1390: STRONGER Patents Act ---H.R. 6264: Restoring America's Leadership Act ---Biomedical Innovation Protection Act of 2018 (Discussion Draft House/Senate) North American Free Trade Agreement (NAFTA) Renegotiation ---IP Provisions Patenting of Biological Inventions ---PTO Examination Guidelines ---Section 101 Modernization Patent Reform ---H.R. 5340/S. 1390: STRONGER Patents Act

LobbyistCovered position, as disclosed
MELISSA BRAND —
JOSEPH DAMOND —
CHARLES H FRITTS —
JEANNE HAGGERTY —
KYLE KUNKLER —
SARAH KYLE —
DAVID LACHMANN —
JORDAN LAYSON —
MATTHEW O'MARA —
HANSJORG SAUER —

Contacted: Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); State, Dept of (DOS); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Council of Economic Advisers (CEA); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); SENATE; Food & Drug Administration (FDA); White House Office

Bills named: H.R. 6264 (115th), H.R. 5340 (115th), S. 1390 (115th)

Medicare/Medicaid MMM

Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculation Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6142/S. 2042: Reducing Drug Waste Act

LobbyistCovered position, as disclosed
TAYLOR BOOTH —
JEANNE HAGGERTY —
SARAH KYLE —
JORDAN LAYSON —
JOHN MURPHY —

Contacted: Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); White House Office; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Securities & Exchange Commission (SEC); Office of Management & Budget (OMB); SENATE; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Council of Economic Advisers (CEA)

Bills named: S. 771 (115th), H.R. 6142 (115th), S. 2042 (115th), S. 1688 (115th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title) ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---Nomenclature Usage ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R. 3149/S.1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S.2005: Master Limited Partnership Parity Act

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
CHARLES H FRITTS —
JEANNE HAGGERTY —
KYLE KUNKLER —
ERICK LUTT —
RINA SINGH —

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Council of Economic Advisers (CEA); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Natl Economic Council (NEC); Natl Institutes of Health (NIH); Office of Management & Budget (OMB)

Bills named: H.R. 5961 (115th), H.R. 4118 (115th), S. 1980 (115th), S. 3042 (115th), S. 2005 (115th), H.R. 2 (115th), S. 2976 (115th), H.R. 3149 (115th)

Consumer Issues/Safety/Products CSP

Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 ------Amendment on GE Salmon Labeling Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

Contacted: Office of Science & Technology Policy (OSTP); White House Office; Council of Economic Advisers (CEA); Office of Management & Budget (OMB); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); SENATE; Natl Institutes of Health (NIH)

Bills named: S. 2476 (115th), S. 2680 (115th), H.R. 6 (115th), H.R. 5473 (115th), S. 2769 (115th), S. 2665 (115th), H.R. 5002 (115th), S. 2669 (115th), H.R. 5961 (115th), H.R. 5806 (115th), H.R. 5590 (115th), S. 469 (115th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing --------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 ------Amendment on GE Salmon Labeling Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
JEANNE HAGGERTY —
DAN JENKINS —
KYLE KUNKLER —
JORDAN LAYSON —
DANA MAURICE O'BRIEN —

Contacted: Council of Economic Advisers (CEA); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); White House Office; Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA)

Animals ANI

Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 ------Amendment on GE Salmon Labeling One Health ---S. 2615: Advancing Emergency Preparedness Through One Health Act

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
JEANNE HAGGERTY —
DAN JENKINS —
KYLE KUNKLER —
JORDAN LAYSON —
DANA MAURICE O'BRIEN —

Contacted: White House Office; Agriculture, Dept of (USDA); Council of Economic Advisers (CEA); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 5961 (115th), S. 2476 (115th), S. 2615 (115th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) ---S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
PHYLLIS ARTHUR —
TAYLOR BOOTH —
JAMIE GREGORIAN —
JEANNE HAGGERTY —
SARAH KYLE —
JORDAN LAYSON —
PHI D VU —

Contacted: Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Natl Economic Council (NEC); White House Office; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Council of Economic Advisers (CEA); Patent & Trademark Office (PTO); SENATE; State, Dept of (DOS); Natl Institutes of Health (NIH)

Bills named: S. 2852 (115th), S. 3158 (115th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) ---S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA) Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
PHYLLIS ARTHUR —
TAYLOR BOOTH —
JAMIE GREGORIAN —
JEANNE HAGGERTY —
SARAH KYLE —
JORDAN LAYSON —
PHI D VU —

Contacted: U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); State, Dept of (DOS); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Security Council (NSC); Council of Economic Advisers (CEA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); White House Office; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Bills named: S. 3158 (115th), S. 2976 (115th), S. 2852 (115th), H.R. 5961 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.